ENDPOINTS

Covid-19 roundup: Moderna CEO Stéphane Bancel becomes a billionaire; Novartis, Incyte pitch Jakafi PhIII to tackle ...

6 years ago

R&D

Coronavirus

Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T

6 years ago

News Briefing

Covid-19 roundup: Trump pushes his new favorite, untested drug; CRISPR outlines crippling impact of Covid-19

6 years ago

Coronavirus

Myovant grabs $40M upfront in regional deal for relugolix; Akero announces NASH success but Covid-19 delays

6 years ago

News Briefing

Covid-19 roundup: GSK, Amgen tailor R&D work to fit the coronavirus age; Doudna's genomics crew launches diagnostic ...

6 years ago

Coronavirus

Jim Robinson takes over the reins at Urovant; Carlos Campoy moves to CytomX

6 years ago

Peer Review

Covid-19 roundup: Intercept, bluebird and a growing list of biotechs feel the pain as pandemic mangles FDA, R&D ...

6 years ago

Coronavirus

Oprah day in biotech: Regenacy gets $30M, Abbisko gets $70M, Castle Creek gets $75M

6 years ago

News Briefing

BELLUS Health buys IP rights, banishes royalties; AbbVie gets confirmatory data on accelerated AML drug

6 years ago

News Briefing

Covid-19 roundup: FDA stamps quick OK on Roche's Actemra PhIII; AlloVir expands Baylor pact

6 years ago

Coronavirus

Charles Bancroft makes quick leap from Bristol Myers exec team to GSK; Medicxi adds two new partners to its team

6 years ago

Peer Review

Biogen sues company allegedly selling aducanumab copycat; J&J takes on Novartis' MS franchise

6 years ago

News Briefing

Insilico inks another deal with Sino Biopharma unit; Ramaswamy's Datavant to invest in the "patient journey"

6 years ago

News Briefing

Rick Klausner's Lyell partners, helps fund Eureka's work on cell therapies; Blueprint bounces higher on PhII

6 years ago

News Briefing

CureVac’s Ingmar Hoerr tells us why he returned to take on a pandemic; NGM loses a president

6 years ago

Peer Review

Bristol Myers scores new FDA nod for Opdivo/Yervoy combo; US Army wants Gilead's potential Covid-19 drug for infected ...

6 years ago

News Briefing

Syneos up for sale — report; Takeda's Ninlaro fails PhIII in multiple myeloma; EMA braces for drug shortage

6 years ago

News Briefing

Inovio files for $50M offering amid Covid-19 vaccine hunt; Zydus Cadila signs on with XOMA on IL-2 deal

6 years ago

News Briefing

Coronavirus update: Trump signs $8.3B spending bill into law; Pfizer considers mRNA vaccine pact with BioNTech

6 years ago

News Briefing

Abraxane developer Iglesias joins Senti Biosciences; AB2Bio recruits CEO

6 years ago

Peer Review

Bristol-Myers joins forces with digital therapeutics co; Wearable cardioverter defibrillator scores $145M+ in Series ...

6 years ago

News Briefing

After the field left her behind, a scientist-turned-investor gets her first R&D job; Nouscom finds new leadership for ...

6 years ago

Peer Review

Sage confirms suspension of 2 depression trials after PhIII flop; Esperion follows up maiden approval with combo OK

6 years ago

News Briefing

Scott Gottlieb in the running for possible coronavirus czar; The drug Vanda sued the FDA over fails a pivotal study

6 years ago

News Briefing

about the author

author articles

Covid-19 roundup: Moderna CEO Stéphane Bancel becomes a billionaire; Novartis, Incyte pitch Jakafi PhIII to tackle ...

Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T

Covid-19 roundup: Trump pushes his new favorite, untested drug; CRISPR outlines crippling impact of Covid-19

Myovant grabs $40M upfront in regional deal for relugolix; Akero announces NASH success but Covid-19 delays

Covid-19 roundup: GSK, Amgen tailor R&D work to fit the coronavirus age; Doudna's genomics crew launches diagnostic ...

Jim Robinson takes over the reins at Urovant; Carlos Campoy moves to CytomX

Covid-19 roundup: Intercept, bluebird and a growing list of biotechs feel the pain as pandemic mangles FDA, R&D ...

Oprah day in biotech: Regenacy gets $30M, Abbisko gets $70M, Castle Creek gets $75M

BELLUS Health buys IP rights, banishes royalties; AbbVie gets confirmatory data on accelerated AML drug

Covid-19 roundup: FDA stamps quick OK on Roche's Actemra PhIII; AlloVir expands Baylor pact

Charles Bancroft makes quick leap from Bristol Myers exec team to GSK; Medicxi adds two new partners to its team

Biogen sues company allegedly selling aducanumab copycat; J&J takes on Novartis' MS franchise

Insilico inks another deal with Sino Biopharma unit; Ramaswamy's Datavant to invest in the "patient journey"

Rick Klausner's Lyell partners, helps fund Eureka's work on cell therapies; Blueprint bounces higher on PhII

CureVac’s Ingmar Hoerr tells us why he returned to take on a pandemic; NGM loses a president

Bristol Myers scores new FDA nod for Opdivo/Yervoy combo; US Army wants Gilead's potential Covid-19 drug for infected ...

Syneos up for sale — report; Takeda's Ninlaro fails PhIII in multiple myeloma; EMA braces for drug shortage

Inovio files for $50M offering amid Covid-19 vaccine hunt; Zydus Cadila signs on with XOMA on IL-2 deal

Coronavirus update: Trump signs $8.3B spending bill into law; Pfizer considers mRNA vaccine pact with BioNTech

Abraxane developer Iglesias joins Senti Biosciences; AB2Bio recruits CEO

Bristol-Myers joins forces with digital therapeutics co; Wearable cardioverter defibrillator scores $145M+ in Series ...

After the field left her behind, a scientist-turned-investor gets her first R&D job; Nouscom finds new leadership for ...

Sage confirms suspension of 2 depression trials after PhIII flop; Esperion follows up maiden approval with combo OK

Scott Gottlieb in the running for possible coronavirus czar; The drug Vanda sued the FDA over fails a pivotal study